Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco

The proposed clinical trial in Africa of VRC01, a potent broadly neutralizing antibody (bNAb) capable of neutralizing 91% of known HIV-1 isolates, raises concerns about testing a treatment which will be too expensive to be accessible by the most important target population, the poor in under-developed regions such as sub-Saharan Africa. Here, we report the expression of VRC01 in plants as an economic alternative to conventional mammalian-cell-based production platforms. The heavy and light chain genes of VRC01 were cloned onto a single vector, pTRAk.2, which was transformed into Nicotiana benthamiana or Nicotiana tabacum using transient and stable expression production systems respectively. VRC01 has been successfully expressed transiently in plants with expression level of approximately 80 mg antibody/kg; stable transgenic lines expressing up to 100 mg antibody/kg were also obtained. Plant-produced VRC01 from both systems showed a largely homogeneous N-glycosylation profile with a single dominant glycoform. The binding kinetics to gp120 IIIB (approximately 1 nM), neutralization of HIV-1 BaL or a panel of 10 VRC01-sensitive HIV-1 Env pseudoviruses of VRC01 produced in transient and stable plants were also consistent with VRC01 from HEK cells

Polystyrene Magadiite Nanocomposites

An organically modified magadiite has been prepared and used to make a mixed intercalated-exfoliated polystyrene nanocomposite by bulk polymerization. This system gives excellent improvement in mechanical properties, but the thermogravimetric analysis curves do not show any change in the onset of the degradation and the degradation pathway is not changed from that for virgin polystyrene, unlike the situation for an aluminosilicate clay, monlmorillonite. By cone calorimetry, the peak heat release rate is not changed, again unlike the results with the aluminosilicate. This suggests that not all clays exhibit the same behavior in nanocomposite formation

Carbon radio recombination lines from gigahertz to megahertz frequencies towards Orion A

Context. The combined use of carbon radio recombination lines (CRRLs) and the 158 $\mu$m-[CII] line is a powerful tool for the study of the energetics and physical conditions (e.g., temperature and density) of photodissociation regions (PDRs). However, there are few observational studies that exploit this synergy. Aims. Here we explore the relation between CRRLs and the 158 $\mu$m-[CII] line in light of new observations and models. Methods. We present new and existing observations of CRRLs in the frequency range 0.15--230 GHz with ALMA, VLA, the GBT, Effelsberg 100m, and LOFAR towards Orion~A (M42). We complement these observations with SOFIA observations of the 158 $\mu$m-[CII] line. We studied two PDRs: the foreground atomic gas, known as the Veil, and the dense PDR between the HII region and the background molecular cloud. Results. In the Veil we are able to determine the gas temperature and electron density, which we use to measure the ionization parameter and the photoelectric heating efficiency. In the dense PDR, we are able to identify a layered PDR structure at the surface of the molecular cloud to the south of the Trapezium cluster. There we find that the radio lines trace the colder portion of the ionized carbon layer, the C$^{+}$/C/CO interface. By modeling the emission of the $158$~$\mu$m-[CII] line and CRRLs as arising from a PDR we derive a thermal pressure $>5\times10^{7}$ K cm$^{-3}$ and a radiation field $G_{0}\approx10^{5}$ close to the Trapezium. Conclusions. This work provides additional observational support for the use of CRRLs and the 158 $\mu$m-[CII] line as complementary tools to study dense and diffuse PDRs, and highlights the usefulness of CRRLs as probes of the C$^{+}$/C/CO interface.Comment: 18 pages, 16 figures, accepted for publication in A&

Probing of local ferroelectricity in BiFeO3 thin films and (BiFeO3)m(SrTiO3)m superlattices

Ferroelectric BiFeO3 thin films and artificial superlattices of (BiFeO3)m(SrTiO3)m (m~ 1 to 10 unit cells) were fabricated on (001)-oriented SrTiO3 substrates by pulsed laser ablation. The variation of leakage current and macroscopic polarization with periodicity was studied. Piezo force microscopy studies revealed the presence of large ferroelectric domains in the case of BiFeO3 thin films while a size reduction in ferroelectric domains was observed in the case of superlattice structures. The results show that the modification of ferroelectric domains through superlattice, could provide an additional control on engineering the domain wall mediated functional properties.Comment: 14 pages, To be published in J. Mag. Mag Mater. proceedings of EMRS 200

Associations between anxiety, body mass index, and sex hormones in women

Background: Several studies have shown a positive association between anxiety and obesity, particularly in women. We aimed to study whether sex hormone alterations related to obesity might play a role in this association. Patients and methods: Data for this study were obtained from a population-based cohort study (the LIFE-Adult-Study). A total of 3,124 adult women (970 premenopausal and 2,154 postmenopausal) were included into the analyses. The anxiety symptomatology was assessed using the GAD-7 questionnaire (cut-off ≥ 10 points). Sex hormones were measured from fasting serum samples. Results: We did not find significant differences in anxiety prevalence in premenopausal obese women compared with normal-weight controls (4.8% vs. 5.5%). Both obesity and anxiety symptomatology were separately associated with the same sex hormone alteration in premenopausal women: higher total testosterone level (0.97 ± 0.50 in obese vs. 0.86 ± 0.49 nmol/L in normal-weight women, p = 0.026 and 1.04 ± 0.59 in women with vs. 0.88 ± 0.49 nmol/L in women without anxiety symptomatology, p = 0.023). However, women with anxiety symptomatology had non-significantly higher estradiol levels than women without anxiety symptomatology (548.0 ± 507.6 vs. 426.2 ± 474.0 pmol/L), whereas obesity was associated with lower estradiol levels compared with those in normal-weight group (332.7 ± 386.5 vs. 470.8 ± 616.0 pmol/L). Women with anxiety symptomatology had also significantly higher testosterone and estradiol composition (p = 0.006). No associations of sex hormone levels and BMI with anxiety symptomatology in postmenopausal women were found. Conclusions: Although both obesity and anxiety symptomatology were separately associated with higher testosterone level, there was an opposite impact of anxiety and obesity on estradiol levels in premenopausal women. We did not find an evidence that the sex hormone alterations related to obesity are playing a significant role in anxiety symptomatology in premenopausal women. This could be the explanation why we did not find an association between obesity and anxiety. In postmenopausal women, other mechanisms seem to work than in the premenopausal group